JPRN-UMIN000013019CompletedPhase 2
Phase 2 study of alternate-day administrations of S-1 in elderly patients with advanced/recurrent gastric cancer (KDOG 1301) - Phase 2 study of alternate-day administrations of S-1 in elderly patients with gastric cancer (KDOG 1301)
Department of Gastroenterology, Kitasato University School of Medicine0 sites6 target enrollmentStarted: January 30, 2014Last updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 6
Study Overview
Brief Summary
Clinical trial discontinued due to sluggish accumulation of 6 registered cases
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 76years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. History of hypersensitivity for S-1 or ingredients of S-1 2. Patient who takes flucytosine, or phenytoin 3. Severe bone marrow suppression, severe renal dysfunction, or severe liver dysfunction 4. Severe concomitant disease (congestive heart failure, hemorrhagic peptic ulcer, ileus, symptomatic ischemic heart disease, liver cirrhosis, interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema or etc) 5. Patient who suffered from myocardial infarction or cerebral infarction within six months 6. symptomatic brain metastasis 7. Severe mental disorders 8. Active synchronous malignancy 9. Watery diarrhea 10. HBV carrier who has to take nucleotide analogues (e.g. Entecavir) during chemotherapy 11. Patient who is judged inappropriate for the entry into this study by the investigator
Investigators
Similar Trials
Completed
Phase 2
Efficacy and safety of weekly nab-paclitaxel plus CBDCA in patients with CUPcancer of unknown primaryCUP, nab-Paclitaxel,CBDCAJPRN-jRCTs051180084Yagi Toshinari17
Completed
Phase 2
A phase II study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinomagastric cancerJPRN-UMIN000003201Study group of multi-modality therapy for gastric cancer5
Completed
Phase 2
Phase II trial of neoadjuvant chemotherapy for unresectable liver metastasis of colorectal cancerColorectal cancer patients with unresectable liver metastasisJPRN-UMIN000006994Surgery, Kyorin university hospital10
Completed
Phase 2
A Study of Rilematovir (JNJ-53718678) in Adult Outpatients with Respiratory Syncytial Virus (RSV) InfectioJPRN-jRCT2031210527akama Takahiro5
Terminated
Phase 3
Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.Levodopa Induced Dyskinesias (LID)Parkinson's DiseaseNCT02153645Adamas Pharmaceuticals, Inc.87